The Government Accountability Office found breakdowns in the way the Food and Drug Administration evaluates drugs for rare diseases. The analysis came after an investigation by Kaiser Health News.
(Image credit: Al Drago/CQ Roll Call/Getty Images)
from News : NPR https://ift.tt/2SoaoRS
No comments:
Post a Comment